平潭發展(000592.SZ):控股股東預計被動減持1931.78萬股
格隆匯9月8日丨平潭發展(000592.SZ)公佈,公司於2020年9月8日收到控股股東山田實業的告知函,獲悉因山田實業的非控股股東存在未能履行融資業務相關協議約定的情形,山田實業為其非控股股東融資業務提供擔保所質押的平潭發展部分股份,可能繼續被質權人廈門信託實施違約處置而導致被動減持。
截止本披露日,山田實業持有公司4.52億股股份,佔公司總股份的23.40%。公司控股股東山田實業將原持有公司的2.142億股股份質押給廈門信託,預計被動減持股份數為1931.78萬股,佔公司股份總數的0.9999995%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.